Goldman Sachs Reportedly Selected to Lead SpaceX IPO in Potential Landmark Market Debut Trainline Lifts FullYear Guidance Again on Strong Booking Demand Divis Laboratories Reports 13 PAT Growth in Q4 Declares Rs 30 Dividend Pope Leo XIV Warns of AIDriven Moral Collapse Raising Ethical Stakes for Tech Sector Fed Dissenters Explain No Votes Disagreed with Hinting Next Move Would Be a Cut Hindalco Faces Q4 Profit Halving but Bullish Metal Prices and Novelis Restart Lift MediumTerm Outlook EDUC Q1 2026 Earnings Educational Development Corporation Reports Loss Amidst Unclear Revenue Picture NSIT Q1 2026 Earnings Strong EPS Beat Drives Stock Up 31 Dave Busters PLAY Q1 2026 Earnings Massive EPS Miss Sends Stock Higher TGEN Q1 2026 Earnings EPS Surprises to the Upside Stock Rises 79 Mosaic Company MOS Q1 2026 Earnings EPS Falls Short by 79 Stock Rises Unexpectedly Solventum SOLV Q1 2026 Earnings EPS Beats Estimates by 734 Revenue Details Unreported LENZ Therapeutics LENZ Edges Lower as Stock Tests Support at 730 Imperial Petroleum Preferred Shares IMPPP Edge Higher Amid Steady Yield Appeal Pioneer Bancorp Inc PBFS Shows Mild Uptick Amid Consolidation Above Key Support AgEagle Aerial Systems UAVS Posts Modest Gain at 106 Resistance at 111 in Focus Waste Connections Inc WCN Holds Steady Near Resistance as Volume Remains Subdued Palantir Technologies AI Stock Poised for Potential Growth Surge Shinhan Financial Group Q4 2025 Earnings EPS Miss of 35 on Higher Provisions Lake Shore Bancorp LSBK Holds Steady Near Key Support as Trading Range Narrows Insperity Q1 2026 Earnings EPS Beat Drives Strong Stock Reaction DBD Q1 2026 Earnings EPS Beats Estimates Shares Rise on Profitability Strength KB Financial Group Q4 2025 Earnings Strong EPS Beat Offsets Modest Stock Decline BRBS Q1 2026 Earnings Positive EPS Surprise Amid Market Headwinds TISI Q1 2026 Earnings Widening Losses as Company Navigates Challenging Market Conditions ALGT Q1 2026 Earnings EPS Surges Past Estimates Despite Revenue Discontinuation Autolus Therapeutics Q1 2026 Earnings WiderthanExpected Loss as PreRevenue Biotech Advances Pipeline